Source: Red Light Holland Corp.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Red Light Holland (TRIP) subsidiary Radix Motion has received an International Preliminary Report on Patentability on the patent application filed in July 2020
  • All seven claims directed to the use of 3D movement data in psychedelic therapy were found by an examiner from the United States Patent and Trademark Office to be novel, have an inventive step (be non-obvious), and have industrial applicability (utility)
  • Red Light Holland (TRIP) is an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws
  • Red Light Holland (TRIP) is trading at C$0.09 as of 12:30 pm ET

Red Light Holland (TRIP) subsidiary Radix Motion has received an International Preliminary Report on Patentability on the patent application filed in 2020.

All seven claims directed to using 3D movement data in psychedelic therapy were found by an examiner from the United States Patent and Trademark Office to be novel, have an inventive step (be non-obvious), and have industrial applicability (utility).

The examiner found that for the aforementioned claims, “prior art does not teach or fairly suggest the claimed subject matter,” rendering them allowable and eligible for fast-track examination under the Patent Prosecution Highway in the United States, Canada and other participating patent offices.

Sarah Hashkes, Chief Innovation Officer of Red Light Holland and CEO of Radix Motion, says:

“By combining psychedelic usage data with technology that understands our bodies and how we move, we can have the ability to customize treatments and interventions to increase potential benefits as well as utilize objective data for research and legalization efforts.”

Graham Pechenik, Red Light Holland’s patent advisor, says:

“I’m very excited to be part of Radix Motion and Red Light Holland’s unique and ethical approach to patents that take into account user privacy and seek to protect innovative technology. This is a great step towards the possibility of being granted a patent – the opinion indicates that all of the method claims relating to psychedelic therapy are allowable as written, and it suggests how the broader claims can be amended to cover the inventors’ contributions in ways that are allowable too.”

Todd Shapiro, CEO and Director of Red Light Holland, says:

“Red Light Holland continues to work with a stellar team to protect our unique intellectual property aimed at increasing the benefits and responsible access to natural psilocybin.”

Radix Motion is a technology company founded in Silicon Valley focused on building immersive and embodied technology for health and wellness, including interactive education that explains what psychedelics do to the brain and more.

Red Light Holland (TRIP) is an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws.

Red Light Holland (TRIP) is trading at C$0.09 as of 12:30 pm ET.


More From The Market Herald

" Field Trip Health & Wellness (TSXV:FTHW) begins trading on the OTC Market

Field Trip Health & Wellness (FTHW) has received approval to start trading on the OTCQB Market in the United States.

" Revive Therapeutics (CSE:RVV) & PharmaTher (CSE:PHRM) sign MDMA research collaboration agreement

Revive Therapeutics (RVV), and PharmaTher (PHRM) have signed a research collaboration agreement.

" Numinus (TSX:NUMI) receives Health Canada approval for psychedelic tea therapy

Numinus Wellness (NUMI) has received approval from Health Canada for its experiential training study.